Regulatory actions for July 21, 2026Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Aspen Pharmacare, Bioarctic, Clinuvel, Eisai, Orasis, Shionogi, Sichuan Biokin, Systimmune.